Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
After reconstitution, follow your institutional SOP for temperature, light exposure, and working-solution stability
Zepbound vs Mounjaro: Head-to-Head Efficacy Comparison At a glance Active ingredient / tirzepatide (dual GIP/GLP-1 receptor agonist) in both products Manufacturer / Eli Lilly for both Zepbound and Mounjaro Zepbound FDA approval / November 2023 for chronic weight management Mounjaro FDA approval / May 2022 for type 2 diabetes (T2D) SURMOUNT-1 weight loss / 20.9% mean body-weight reduction at 72 weeks (15 mg dose) SURPASS-2 A1C reduction / up to 2.3 percentage points vs 1.86 for semaglutide 1 mg Dose range / 2.5 mg to 15 mg weekly subcutaneous injection for both brands Head-to-head trial / none exists
Get doctor approval Always consult with your healthcare provider before considering GLP-1 medications
2022 The major difference between these agents lies in canagliflozin, which is less selective for SGLT2 over SGLT1 and is metabolized primarily in the liver (compared to kidneys), and sotagliflozin, which inhibits both SGLT1 and SGLT2
Risks cited by the regulator Health Canada said unauthorized or counterfeit products may contain too much, too little, or none of the active ingredient, and may include unlisted ingredients or contaminants such as solvents, heavy metals, particles, or microbials
Those bad in melanin have a lighter skin tone
